TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ALMS

Alumis Inc

Healthcare · Biotechnology · —

7.10$ -2.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Alumis Inc (ALMS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 561 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ALMS
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– 90 177 265 413 341 261 611 488 412 672 561
– 53 141 225 377 306 226 518 393 318 532 514
– 46 112 155 213 170 129 152 65 90 64 64
– 49 134 210 362 288 209 486 378 309 523 502
– 0.7 0.6 0.9 1.1 1.8 1.3 7.9 3.6 2.1 2.7 3.9
– – – – – – – 51 51 51 51 9.1
– 429 563 704 64 81 93 126 103 111 105 108
– 21 24 33 34 51 60 86 65 73 71 76
– 1.7 1.6 1.5 1.5 1.6 2.5 4.1 4.4 4.7 4.4 4.8
– 1.1 6.8 9.2 6.4 9.6 7.5 15 4.6 10 12 13
– -339 -386 -439 348 260 168 485 385 301 567 452
– -364 -414 -471 -564 -659 -758 -698 -809 -902 -995 -1,137
38 52 52 54 54 54 54 77 104 105 125 128

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?